| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | US6777407 7bh-cyclopenta(b)(1,4)diazepino(6, 7, 1-hi)indole or a salt, useful for treatment of schizophrenia, obsessive compulsive disorder, depression, anxiety, panic disorder, obesity or epilepsy |
| 08/17/2004 | US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists |
| 08/17/2004 | US6776992 Methods for treating tension headache |
| 08/17/2004 | US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 08/17/2004 | CA2295861C Method of preparing a transgenic non-human animal expressing p25 |
| 08/17/2004 | CA2254658C New naphtalene compounds, their method of preparation and pharmaceutical compositions containing these compounds |
| 08/17/2004 | CA2241611C Chronic, bolus administration of d-threo methylphenidate |
| 08/12/2004 | WO2004067703A2 5ht7 antagonists and inverse agonists |
| 08/12/2004 | WO2004067568A2 Human il-1 beta antagonists |
| 08/12/2004 | WO2004067558A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | WO2004067550A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 08/12/2004 | WO2004067535A1 Thienopyrimidine compounds and use thereof |
| 08/12/2004 | WO2004067524A1 Ep4 receptor antagonists |
| 08/12/2004 | WO2004067520A1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors |
| 08/12/2004 | WO2004067513A1 Antagonists for alpha-2 adrenoceptors |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004067010A1 Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases |
| 08/12/2004 | WO2004067007A1 NEW CRYSTALLINE MODIFICATION OF 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4(4-FLUORO-2-METHYL-PHENYL)-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 08/12/2004 | WO2004067002A2 SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT |
| 08/12/2004 | WO2004066999A1 Compositions containing 2, 2’ -methylenebisbenzimidazole derivatives for treating ischemia-related neuronal damage |
| 08/12/2004 | WO2004066998A1 Stable solid medicinal composition for oral administration |
| 08/12/2004 | WO2004066932A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066931A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004056799A3 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2004 | WO2004052858A3 Inhibitors of monoamine uptake |
| 08/12/2004 | WO2004050019A3 Method and compositions for treating anxiety |
| 08/12/2004 | WO2004033691A3 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 08/12/2004 | WO2004026857A3 Methods of purifying cannabinoids from plant material |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004020623A3 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 08/12/2004 | WO2003106444A8 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 08/12/2004 | WO2003037863A3 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040158077 Process for preparation of imidazolyl compounds |
| 08/12/2004 | US20040158076 Tyrosine derivatives |
| 08/12/2004 | US20040158060 Multistage reaction of carbamazepine with peroxyacetic acid and metal catalyst in solvent and catalytic hydrogenation |
| 08/12/2004 | US20040158036 Neuritogenic compound and uses thereof |
| 08/12/2004 | US20040157934 Central nervous system disorders; psychological disorders ; administering dosage og dopamine, serotonin and sibutramine |
| 08/12/2004 | US20040157930 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 08/12/2004 | US20040157926 Pharmaceutical compositions for the treatment of movement disorders |
| 08/12/2004 | US20040157917 Central nervous system disorders; psychological disorders |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157913 Irritable bowel syndrome ; gastrointestinal disorders |
| 08/12/2004 | US20040157908 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157890 Dyslipidemia; cardiovascular disorders; antidiabetic agents; eating disorders; antiinflammatory agents; anticholesterol agents |
| 08/12/2004 | US20040157889 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 08/12/2004 | US20040157888 Method of treating of demyelinating diseases or conditions |
| 08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
| 08/12/2004 | US20040157884 Accurate, long duration, controlled release of opioids at small dosage levels; implants; minimizing tissue trauma |
| 08/12/2004 | US20040157878 Alzheimer 's disease; parkinson's disease; schizophrenia; antidepressants; anxiolytic agents; brain disorders; psychological disorders |
| 08/12/2004 | US20040157876 Solid dosage forms; melt granulation |
| 08/12/2004 | US20040157870 for treating or preventing attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder |
| 08/12/2004 | US20040157869 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157860 Pyrazine compounds as CRF modulators |
| 08/12/2004 | US20040157858 Piperazine derivatives as tachykinin antagonists |
| 08/12/2004 | US20040157857 Substituted chroman derivatives |
| 08/12/2004 | US20040157854 CCRS antagonists useful for treating aids |
| 08/12/2004 | US20040157850 Novel heterocyclic derivatives |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157839 substituted pyrazolo[1,5-a][1,3,5]triazine compounds; in particular CB1 receptor antagonists |
| 08/12/2004 | US20040157838 pyrazolo[1,5-a]pyrimidine compounds; in particular CB1 receptor antagonists; antiobesity; antidepressant |
| 08/12/2004 | US20040157831 Therapeutic 5-HT ligand compounds |
| 08/12/2004 | US20040157830 Formailide derivatives as beta2-adrenoreceptor agonists |
| 08/12/2004 | US20040157829 useful in the treatment of central or peripheral nervous system disorders(e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, epilepsy, hearing and vision loss, Alzheimer's disease, etc.) and as neuroprotective agent |
| 08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/12/2004 | US20040157823 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
| 08/12/2004 | US20040157822 Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 08/12/2004 | US20040157817 Cycloalkenylsulfonamide derivatives |
| 08/12/2004 | US20040157806 4-Dedimethylamino tetracycline compounds |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157225 pharmaceuticals, kits and recombinant animal models for prognosis/prevention |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040156901 Pharmaceutical composition of topiramate |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156820 Adjuvant combination formulations |
| 08/12/2004 | US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 08/12/2004 | US20040156790 Delivery of drug esters through an inhalation route |
| 08/12/2004 | US20040156789 Delivery of antihistamines through an inhalation route |
| 08/12/2004 | US20040156788 Delivery of erectile dysfunction drugs through an inhalation route |
| 08/12/2004 | CA2514656A1 5ht7 antagonists and inverse agonists |
| 08/12/2004 | CA2514125A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2514117A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2513699A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | CA2511610A1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors |
| 08/12/2004 | CA2509136A1 Human il-1 beta antagonists |
| 08/11/2004 | EP1445615A1 Method for discrimination between infectious and noninfectious prions |
| 08/11/2004 | EP1445315A1 Human and mammalian stem cell-derived neuronal survival polypeptides |
| 08/11/2004 | EP1445314A1 Novel glutamic acid receptor and utilization thereof |